Although the concept that dendritic cells (DCs) recognize pathogens through the engagement of Toll-like receptors is widely accepted, we recently suggested that immature DCs might sense kinin-releasing strains of Trypanosoma cruzi through the triggering of G-protein-coupled bradykinin B2 receptors (B2R). Here we report that C57BL/6.B2R−/− mice infected intraperitoneally with T. cruzi display higher parasitemia and mortality rates as compared to B2R+/+ mice. qRT-PCR revealed a 5-fold increase in T. cruzi DNA (14 d post-infection [p.i.]) in B2R−/− heart, while spleen parasitism was negligible in both mice strains. Analysis of recall responses (14 d p.i.) showed high and comparable frequencies of IFN-γ-producing CD4+ and CD8+ T cells in the spleen of B2R−/− and wild-type mice. However, production of IFN-γ by effector T cells isolated from B2R−/− heart was significantly reduced as compared with wild-type mice. As the infection continued, wild-type mice presented IFN-γ-producing (CD4+CD44+ and CD8+CD44+) T cells both in the spleen and heart while B2R−/− mice showed negligible frequencies of such activated T cells. Furthermore, the collapse of type-1 immune responses in B2R−/− mice was linked to upregulated secretion of IL-17 and TNF-α by antigen-responsive CD4+ T cells. In vitro analysis of tissue culture trypomastigote interaction with splenic CD11c+ DCs indicated that DC maturation (IL-12, CD40, and CD86) is controlled by the kinin/B2R pathway. Further, systemic injection of trypomastigotes induced IL-12 production by CD11c+ DCs isolated from B2R+/+ spleen, but not by DCs from B2R−/− mice. Notably, adoptive transfer of B2R+/+ CD11c+ DCs (intravenously) into B2R−/− mice rendered them resistant to acute challenge, rescued development of type-1 immunity, and repressed TH17 responses. Collectively, our results demonstrate that activation of B2R, a DC sensor of endogenous maturation signals, is critically required for development of acquired resistance to T. cruzi infection.
Antibodies and IFN-γ-producing effector T cells are essential for the immune control of infection by Trypanosoma cruzi, the intracellular protozoa that causes human Chagas disease. Despite the potency of anti-parasite immunity, the parasites are not cleared from their intracellular niches. Instead, a low grade chronic infection prevails, provoking severe immunopathology in the myocardium. Although it is well established that innate sentinel cells sense T. cruzi through receptors for microbial structures, such as Toll-like receptors, it remained unclear whether endogenous inflammatory signals also contribute to the development of adaptive immunity. The present study was motivated by awareness that T. cruzi trypomastigotes (extracellular infective forms) are equipped with proteases that liberate the pro-inflammatory bradykinin peptide from an internal segment of kininogens. Here we demonstrate that splenic dendritic cells (DCs), the antigen-presenting cells that coordinate the adaptive branch of immunity in lymphoid tissues, are potently activated via G-protein-coupled bradykinin B2 receptors (B2R). Analysis of the outcome of infection in B2R-knockout mice revealed that the mutant mice developed a typical susceptible phenotype, owing to impaired development of IFN-γ-producing effector T cells. Notably, the immune dysfunction of B2R-knockout mice was corrected upon cell transfer of wild-type DCs, thus linking development of protective T cells to DCs' sensing of endogenous danger signals (kinins) released by trypomastigotes.
Citation: Monteiro AC, Schmitz V, Morrot A, de Arruda LB, Nagajyothi F, Granato A, et al. (2007) Bradykinin B2 Receptors of Dendritic Cells, Acting as Sensors of Kinins Proteolytically Released by Trypanosoma cruzi, Are Critical for the Development of Protective Type-1 Responses . PLoS Pathog 3(11): e185. https://doi.org/10.1371/journal.ppat.0030185
Editor: Eleanor M. Riley, London School of Hygiene and Tropical Medicine, United Kingdom
Received: July 6, 2007; Accepted: October 15, 2007; Published: November 30, 2007
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: Funded by WHO-TDR (IDA10340), VolkswagenStiftung, CNPq, FAPERJ, and by NIH Grant AI 052739.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: ACEi, angiotensin-converting enzyme inhibitor; Ag, antigen; APC, antigen-presenting cell; BK, bradykinin; BR, bradykinin receptor; CpG, cytosine-phosphate-guanine; CZP, cruzipain; DC, dendritic cell; EPI, epimastigote; FACS, fluorescent activated cell sorting; LPS, lipopolysaccharide; p.i., post-infection; PRR, pattern recognition receptor; qPCR, real-time PCR; TCT, tissue culture trypomastigotes; TH17, IL-17-producing CD4+ T cells; TLR, Toll-like receptor; VSPh, methylpiperazine-Phe-homoPhe-vinylsulfone-benzene
Chagas disease, the chronic cardiomyopathy caused by infection with the intracellular parasitic protozoan Trypanosoma cruzi, remains a major health problem in Central and South America . Although acute Chagas disease may have a fatal outcome, the blood parasitemia, tissue parasite burden (liver, spleen, and heart), and the inflammatory sequel tend to subside with the onset of adaptive immunity. After several years of asymptomatic infection, approximately 30% of infected patients develop a chronic and progressive form of cardiomyopathy . While not excluding a secondary pathogenic role for autoimmunity, studies in humans and animal models support the concept that parasite persistence in myocardial tissues is the primary cause of chronic immunopathology [3–6]. Cohort studies with chagasic patients have linked chronic heart pathology to TH1-type responses , but this proposition was recently called into question by a report indicating that the frequency of IFN-γ-producing effector/memory T cells is inversely correlated with the severity of chronic Chagas disease . Animal model studies established that acquired resistance depends on development of serum antibodies as well as on IFN-γ-producing CD4+ and CD8+ T cells [9–12]. Recent studies indicated that CCR5 has a suceptible phenotype, attributed to impaired recruitment of effector T cells to parasitized heart tissues [13,14]. Although the dominant epitope specificities recognized by cytotoxic CD8 T cells are encoded by highly polymorphic genes , it is still unclear how T. cruzi escapes from immune surveillance [16–18].
In the present work, we set out to investigate the mechanims linking innate to adaptive immunity in the mouse model of T. cruzi infection. Early studies about innate resistance mechanisms indicated that macrophages upregulate nitric oxide (NO)-dependent trypanocydal responses  due to ligand-induced signaling of Toll-like 2 receptors (TLR2) [20,21] or TLR4 . More recently, Bafica et al. reported that macrophages sense T. cruzi DNA via triggering of intracellular TLR9 . Interestingly, they showed that acute infection is more severe in TLR2−/− TLR9−/− mice than in TLR9−/− mice or either TLR2−/−-  or TLR4-deficient mice , albeit not as much as in the overtly susceptible MyD88−/− mice . While not formally excluding an additive innate role for TLR4, these collective studies suggested that cooperative activation of TLR2 and TR9 may account for the bulk of protective IFN-γ responses generated by MyD88-dependent signaling pathways [23,24]. Of note, analysis of macrophage activation by MyD88-independent pathways revealed that TLR/TRIF coupling promotes NO-dependent microbicidal responses through upregulation of type I interferons [25,26]. In spite of evidence that mice deficient in IL-12  are highly susceptible to T. cruzi infection, it is still uncertain if induction of TH1-responses is strictly dependent on dendritic cell (DC) maturation by TLRs/MyD88-dependent pathways. Pertinently, it was reported that spleen cells from MyD88−/− mice display small yet significant production of IL-12 and IFN-γ [24,28]. These observations imply that IL-12-dependent Th1 responses may be also controlled by MyD88-independent mechanisms, such as the NKT/CD1d pathway , or by endogenously released bradykinin (BK), an endogenous danger signal driving DC maturation [30–32].
“Kinins”, a small group of mediators related to the nonapeptide BK, activate immature DCs  as well as several other cell types through the binding to distinct subtypes of G-protein-coupled receptors: B2R (constitutive) and B1R (inducible) [33–36]. The B2R agonists, BK or lysyl-BK (LBK), are proteolytically excised from an internal segment of their parental (glyco)proteins, high or low molecular weight kininogens, by plasma or tissue kallikreins, respectively . In the settings of infections, however, kinins can be generated through the direct action of microbial cysteine proteases, such as gingipain of Porphyromonas gingivalis  and cruzipain (CZP), the major cysteine protease of T. cruzi [38–41]. Using a subcutaneous model of T. cruzi infection, we recently demonstrated that trypomastigotes release kinins in peripheral tissues through the activity of CZP . Once liberated from plasma borne–kininogens, the short-lived kinin peptides activate CD11c+DCs via B2R, inducing IL-12 production and stimulating the migration of these antigen-presenting cells (APCs) from the periphery to the draining lymph nodes, where they initiate TH1-like responses against T. cruzi [31,32]. Here we report that B2R-deficient mice infected intraperitoneally by T. cruzi display a typical susceptible phenotype. Adoptive cell transfer experiments demonstrate that CD11c+ DCs activated by the endogenous kinin/B2R-signaling pathway are critically required for the induction and/or maintenance of activated effector CD4+ and CD8+ T cells, while limiting the development of potentially detrimental IL-17-producing CD4+ T cell (TH17) responses in mice acutely infected with T. cruzi.
Infection by the Intraperitoneal Route Discloses a Susceptible Phenotype in B2R−/− Mice
In order to test the hypothesis that kinins may contribute to immune control of T. cruzi infection [30,31], we injected intraperitoneally B2R+/+ C57BL/6 and B2R−/− mice with tissue culture trypomastigotes (TCT) of either Dm28c strain (1 × 106) or Brazil strain (1 × 104). The data shown in Figure 1 indicate that wild-type mice infected with Dm28c TCT developed a low blood parasitemia and all the animals survived (Figure 1A, higher panel). In contrast, B2R−/− mice infected with Dm28c showed a precocious blood parasitemia (day 13 post-infection [p.i.]), which further increased (approximately 3-fold) as the infection continued (23 d p.i.). Mortality rates indicated that B2R−/− mice infected by Dm28c TCT started to die earlier (day 16) than wild-type mice and were all dead by day 27 (Figure 1A, lower panel). We then studied the outcome of infection with the Brazil strain. The results (Figure S1) show that wild-type mice displayed a relatively low blood parasitemia and the mortality rate did not exceed 20%. In contrast, the B2R−/− mice infected by Brazil strain developed increased blood parasitemia, and 80% of these animals were dead by day 28 (Figure S1).
(A) Temporal course of infection with the Dm28c T. cruzi strain in B2R+/+ and B2R−/− mice. Parasitemia and survival curves of mice groups intraperitoneally infected with 1 × 106 TCT of the Dm28c strain of T. cruzi. Parasitemia was evaluated with 5 μl of each infected mouse's blood in an optical microscope. Mortality was recorded daily. The data are representative of two independent experiments (n = 5 mice/group). Statistics were done by ANOVA and pair-wise comparisons were done by the Tukey test (a*, p < 0.05; b* p < 0.01).
(B) Quantification of T. cruzi Dm28c in heart and spleen from infected animals as described above. qPCR was performed as described in Materials and Methods in 100 ng of total DNA at 14 d p.i. Bars represent an average of four to five animals per group ± SD. p < 0.05 between tissue parasitism in heart from wild-type and B2R−/−-infected animals as determined by Student t Test.
We then further characterized the outcome of intraperitoneal infection with the Dm28c strain, using a lower inoculum (6 × 105). Analysis by real-time PCR (qPCR) showed that heart tissues of infected B2R−/− mice (14 d p.i.) contained approximately 5-fold higher content of parasite DNA as compared to wild-type heart (Figure 1B). Surprisingly, we found that the parasite tissue burden in the spleen was very low both in B2R+/+ (0.30 ± 0.09 fg/100 ng host DNA) and B2R−/− (0.46 ± 0.21 fg/100 ng host DNA) mice (Figure 1B). Thus, unlike the scenario observed in extra-lymphoid tissues, parasite outgrowth in the spleen is controlled by mechanisms that do not critically depend on activation of the kinin/B2R pathway, at least so at relatively early stages (14 d) of infection.
Analysis of the Temporal Course of Type-1 Immune Responses in the Spleen
Since the tissue parasitism in the spleen of wild-type and B2R−/− mice (14 d p.i.) was marginal, we checked whether type-1 effector cells were generated in lymphoid tissues of both mice strains. Recall assays indicated that splenocytes from wild-type or B2R−/− vigorously secreted IFN-γ upon stimulation with soluble T. cruzi antigen (Ag) (Figure 2A). Controls showed that, in the absence of T. cruzi soluble Ag, there was no significant production of IFN-γ by the splenocytes (Figure 2A). We then scrutinized the ex vivo recall responses of CD4+ or CD8+ T cells derived from either wild-type or B2R−/− spleen (isolated from infected or naïve mice, as controls) using wild-type CD11c+ DCs (purified from normal spleen) as APCs, to exclude the possibility that eventual defects in Ag processing/presentation by B2R−/− DCs could interfere with our “read-outs”. In keeping with the potent type-1 response elicited by unfractionated wild-type and B2R−/− splenocytes (14 d p.i.), fluorescent activated cell sorting (FACS) analysis showed presence of high and comparable frequencies (Figure 2B, lower panel) of IFN-γ-producing CD4+ and CD8+ T cells in the spleens of wild-type and B2R−/− mice (Figure 2B). Controls performed with Ag-stimulated CD4+ or CD8+ T cells isolated from naïve mice did not generate significant frequencies of IFN-γ-producing cells. Consistent with the similar FACS profiles, ELISA assays showed that IFN-γ was vigorously secreted by Ag-responsive splenic CD4+ or CD8+ T cells, irrespective of the mouse strain origin (Figure 2C).
Infections were performed by inoculation (intraperitoneally) of 6 × 105 TCT (Dm28c). Spleens were removed from infected and non-infected B2R+/+ and B2R−/− mice at 14 d p.i.
(A) Assessment of IFN-γ production by splenocytes stimulated in vitro with T. cruzi Ag (25 μg/ml).
(B) Purified CD4+ and CD8+ T cells were co-cultured with CD11c+ DCs loaded with T. cruzi Ag (25 μg/ml) for 18 h at 37 °C and were stained for CD4 or CD8 and IFN-γ as described in Materials and Methods. Dot plot profiles (n = 5 mice/group) are representative of results observed in four independent experiments. Column graphs (lower panel) indicate the mean ± SD of the frequency of IFN-γ-producing CD4+ or CD8+ T cells (n = 3).
(C) Purified CD4+ and CD8+ T cells were co-cultured with CD11c+ DCs loaded with T. cruzi Ag (25 μg/ml) for 72 h at 37 °C, and supernatants were harvested and assayed for IFN-γ levels by ELISA. Values are the mean ± SD from one representative experiment with individual cells from five mice/group. Statistics were done by ANOVA and pair-wise comparisons were done by the Tukey tests.
We then checked if the presence of type-1 CD4+ and CD8+ effector T cells was maintained in the spleen as the infection continued. Recall assays performed 2 wk later (28 d p.i.) indicated that IFN-γ production by wild-type splenocytes remained vigorous, while the type-1 response of Ag-stimulated B2R−/− splenocytes declined sharply (Figure 3A). We then repeated this analysis using CD4+ or CD8+ T cells purified from the spleens of infected wild-type mice or B2R−/− mice, using wild-type DCs as APCs. Consistent with the data obtained with splenocytes, we found that Ag-stimulated T lymphocytes (CD4+ or CD8+) isolated from B2R−/− spleen (28 d p.i.) secreted significantly lower levels of IFN-γ as compared to wild-type splenic T cells (unpublished data). We then performed FACS analysis to further characterize the phenotypic changes that occurred in the spleen, as the acute infection advanced (28 d p.i.). Our results (Figure 3B) showed that Ag-stimulated T cells isolated from wild-type spleen showed high frequencies of IFN-γ-producing CD4+ and CD8+ T lymphocytes. Moreover, a significant fraction of activated CD4+ and CD8+ T cells isolated from spleen of wild-type infected mice displayed the CD44 surface marker. As expected, addition of Ag to CD4+ or CD8+ T cell cultures from naïve mice did not lead to IFN-γ production (Figure 3B, lower panel). In contrast, B2R−/− spleen presented low frequencies of IFN-γ-producing CD4+ or CD8+ effectors (CD44−) (Figure 3B). Although we have no direct evidence that the Ag-responsive T cells detected ex vivo include functionally active effectors, it is worthwhile mentioning that adoptive transfer of CD4+/CD8+ T cells (isolated from wild-type mice at 60 d p.i.) into B2R−/− mice rendered these recipient mice resistant to lethal infection (0% mortality, n = 5; three independent experiments), as compared to non-manipulated B2R−/− mice (100% mortality) or B2R−/− mice that received CD4+/CD8+ T cells from normal wild-type mice (100% mortality).
(A) Assessment of IFN-γ production by splenocytes isolated from B2R+/+ and B2R−/− mice infected at 28 d with Dm28c TCT. Cells were stimulated with T. cruzi Ag (25 μg/ml) for 72 h at 37 °C. Culture supernatants were harvested and assayed for IFN-γ.
(B) T cells were stimulated with T. cruzi Ag (25 μg/ml) for 18 h at 37 °C and were stained for CD4 or CD8, IFN-γ, and CD44 marker as described in Materials and Methods. Cells from B2R+/+ mice were gated on CD4+IFN-γ+ or CD8+IFN-γ+ lymphocytes and examined for expression of CD44. Dot plot profiles (n = 5 mice/group) are representative of results observed in three independent experiments. Column graphs (lower panel) indicate the mean ± SD of the frequency of IFN-γ-producing CD4+CD44+ or CD8+CD44+ T cells (n = 3). Statistics were done by ANOVA and pair-wise comparisons were done by the Tukey test (*, p < 0.01).
Type-1 Responses by Intracardiac CD4+ and CD8+ T Cells from B2R−/− mice Are Compromised at Early Stages of Infection
As mentioned earlier in this section, we found a 5-fold increase of T. cruzi DNA in the heart of B2R-deficient mice at day 14 p.i., as compared to wild-type heart (Figure 1C). In view of these findings, we set out to determine if cardiac tissues of wild-type and B2R−/− mice contained type-1 effector T cells. Recall assays (again using wild-type splenic CD11c+ DCs as APCs) showed that IFN-γ production by intracardiac B2R−/− CD4+ T cells was significantly diminished (over 50%) as compared to responses elicited by experienced CD4+ T lymphocytes isolated from wild-type heart at 14 d p.i. (p < 0.01) (Figure 4). Similarly, the initial recall response of intracardiac CD8+ T cells isolated from B2R−/− mice was approximately 60% lower than that of wild-type CD8+ T cells (Figure 4).
Assessment of IFN-γ production by heart-derived CD4+ and CD8+ T cells isolated (14 d p.i.) from B2R+/+ and B2R−/− mice. Cells were co-cultured with CD11c+ DCs loaded with T. cruzi Ag (25 μg/ml) for 72 h at 37 °C. Culture supernatants were harvested and assayed for IFN-γ by ELISA. Data are representative of two independent experiments (n = 5 mice/group). Statistics were done by ANOVA and pair-wise comparisons were done by the Tukey test (*, p < 0.05) .
We then checked if the type-1 cytokine response of intracardiac T cells from B2R−/− mice was further compromised as the infection continued. The FACS profiles of wild-type-infected mice (28 d p.i.) revealed high frequencies of IFN-γ-producing intracardiac CD4+ and CD8+ T cells (Figure 5). In addition, we found that the CD44 marker characteristic of activated T cells was present in a significant proportion of wild-type intracardiac CD4+ T cells, and (to lower extent) also in the CD8+ T cell subset (Figure 5, upper and lower panels). In contrast, B2R−/− mice exhibited very low frequencies of CD4+ and CD8+ T cells in the intracardiac CD3+ T cell pool at day 28 p.i. (Figure 5). Following the same trend, IFN-γ-producing CD4+ or CD8+ effector T cells, and activated phenotypes (CD44+CD4+ and CD44+CD8+ T cells) were virtually absent from B2R−/− heart. Collectively, these results suggest that activation of the endogenous kinin/B2R signaling pathway in T. cruzi–infected mice may have an impact on the control mechanisms affecting the temporal and spatial activity of type-1 effectors.
Heart-derived T cells were stimulated with T. cruzi Ag (25 μg/ml) for 18 h at 37 °C and were stained for CD4 or CD8, IFN-γ, and CD44 marker as described in Materials and Methods. Cells from B2R+/+ mice were gated on CD4+IFN-γ+ or CD8+IFN-γ+ lymphocytes and examined for expression of CD44. Dot plot profiles (n = 5 mice/group) are representative of results observed in two independent experiments. Column graphs (lower panel) indicate the mean ± SD of the frequency of IFN-γ-producing CD4+CD44+ or CD8+CD44+ T cells (n = 2). Statistics were done by ANOVA and pair-wise comparisons were done by the Tukey tests (*, p < 0.01).
The Depressed TH1 Response of B2R−/− Infected Mice Is Inversely Correlated with Increased Production of IL-17 and TNF-α
Considering that the type-1 responses of B2R−/− mice were depressed both in the heart (as early as 14 d p.i.) and spleen (28 d p.i.), we then asked if these effects were coupled to TH2 upregulation. Our results indicated that Ag-stimulated T CD4+ T cells (isolated from B2R−/− heart or spleen) did not upregulate IL-4 production (unpublished data). Since IFN-γ inhibits TH17 lineage development in vitro [42,43], we wondered if the reduced TH1 responses observed in B2R−/− mice were accompanied by rises of IL-17- and TNF-α-producing T cells. Recall responses made at 28 d p.i. (Figure 6A) revealed that splenic CD4+ T lymphocytes from wild-type mice did not secrete significant levels of IL-17, while splenic B2R−/− CD4+ T cells upregulated IL-17. The same trend was found when we measured TNF-α levels secreted by experienced B2R−/− CD4+ T cells (Figure 6B). Similar data were obtained when we compared Ag-stimulated responses of intracardiac CD4+ T cells isolated from B2R−/− versus wild-type mice, as discussed later in this section. Collectively, these data suggest that the TH17/TH1 ratio was drastically increased as the acute infection advanced in the highly susceptible B2R−/− mice.
Splenic CD4+ T cells, isolated from infected B2R+/+ and B2R−/− mice (28 d p.i.). T cells were co-cultured with CD11c+ DCs pulsed with T. cruzi Ag (25 μg/ml) for 72 h at 37 °C. Culture supernatants were harvested and assayed for IFN-γ and IL-17 (A) and TNF-α (B) levels by ELISA. Values are the mean ± SD from one representative experiment with individual cells from five mice/group. Statistics were done by ANOVA and pair-wise comparisons were done by the Tukey test (a*, p < 0.05; b*, p < 0.01; *, p < 0.05).
TCT Induce IL-12 Production by Splenic CD11c+ DCs via B2R
Since type-1 responses were impaired in infected B2R−/− mice, we sought to determine if IL-12 responses were preserved, or not, in these mutant mice. To this end, we inoculated Dm28c TCT (1 × 106) intravenously in wild-type and B2R−/− mice, isolated splenic CD11c+ DCs 18 h p.i., and measured IL-12 production by FACS. The results (Figure 7A) showed a marked increase in the frequency of IL-12-producing CD11c+ DCs (8%) in B2R+/+ in relation to non-infected controls (no IL-12 staining). In contrast, splenic CD11c+ DCs isolated from infected B2R−/− mice showed a low frequency (2%) of IL-12-positive cells (Figure 7A). These results were corroborated by ELISA determinations of IL-12 responses produced by DCs isolated from intravenously infected mice (Figure 7B). Of note, we found that macrophages (CD11b+ F4/80+) from infected wild-type and B2R−/− mice show enhanced production of IL-12 as compared to naïve mice, suggesting that alternative mechanisms (i.e., B2R-independent) may govern IL-12 production by splenic macrophages (unpublished data). Extending these in vivo studies to BALB/c mice, these animals were pre-treated, or not, with the B2R antagonist HOE-140 before intravenous injection of TCT. The FACS profiles showed a sharp increase of IL-12-positive CD11c+ DCs in BALB/c mice injected with either TCT (Figure S2) or BK (positive control) (Figure S2). In contrast, BALB/c mice pre-treated with HOE-140 showed a reduced frequency of IL-12-positive CD11c+ DCs (Figure S2). Collectively, the data indicate that B2R drives IL-12 production by splenic DCs, at least at very early stages of the infection.
(A) IL-12 production by splenic CD11c+ DCs of infected mice. B2R+/+ and B2R−/− male mice were infected with 1 × 106 TCT intravenously. Non-infected animals served as control. CD11c+ DCs were isolated from spleen of infected mice at 18 h p.i. and cultured in RPMI complete medium. FACS profiles were done with CD11c-FITC and anti-IL12-PE (n = 6 mice/group).
(B) ELISA determination of IL-12 production by CD11c+ DCs from B2R+/+ and B2R−/− mice non-infected and infected with 1 × 106 TCT intravenously. Statistics were done by ANOVA and pair-wise comparisons were done by the Tukey test (*, p < 0.01).
(C) Intracellular IL-12 produced by splenic CD11c+ DCs of BALB/c mice incubated in vitro with 106 TCT or VSPh-TCT, ratio DC/TCT (1:3), in the presence or absence of 25 μM lisinopril (ACEi) for 18 h, and brefeldin A was added in the final 4 h. In same experiments, 10 nM BK was added to the medium, with or without 0.1 μM HOE-140, 10 μM VSPh, or 10 ng/ml LPS, as indicated. FACS profiles were done with CD11c-FITC and anti-IL12-PE. Each bar represents the % of DCs producing IL-12. Data represent the mean ± SD from six independent experiments. Statistics were done by ANOVA and pair-wise comparisons (represented by a, b, c, d) were done by the Tukey test (*, p < 0.05).
(D) IL-12 levels in supernatants from splenic CD11c+ DC cultures, as above. Statistics were done by ANOVA and pair-wise comparisons (represented by a, b, c, d) were done by the Tukey test (*, p <0.01).
(E) Histograms for CD40 and CD86 expression in splenic CD11c+ DCs. Gray lines represent labeling by anti-CD40-FITC or anti-CD86-FITC, and bold black lines represent labeling by isotype-matched control mAb (rat IgG2a-FITC). Dot plot profiles (n = 5 mice/group) are representative of results observed in at least three independent experiments. Column graphs (lower panel) indicate the mean ± SD of the frequency of CD11c+ CD40+ CD86+ DCs. Statistics were done by ANOVA and pair-wise comparisons were done by the Tukey test (*, p < 0.05).
(F) ELISA determination of IL-12 production by splenic CD11c+ DCs from B2R+/+ versus B2R−/− mice stimulated with TCT. Controls were done with BK (10 nM) and HOE-140 (0.1 μM) in the presence of 25 μM of ACEi (lisinopril). Controls were also performed with LPS (10 ng/ml) and CpG (100 ng/ml) in the presence or absence of HOE-140 (0.1 μM). Data represent the mean ± SD from three independent experiments done in triplicate each. Statistics were done by ANOVA and pair-wise comparisons were done by the Tukey tests (*, p < 0.05).
We then carried out in vitro studies to verify if the parasites could induce the maturation of CD11c+ (splenic) DCs through the activation of the kinin/B2R signaling pathway. IL-12 production and surface expression of co-stimulatory proteins were used as read-out for DC maturation. FACS analyses showed that CD11c+ DCs (BALB/c) did not produce significant IL-12 levels in the absence of parasites (Figure 7C). In contrast, IL-12 production was drastically increased upon addition of exogenous BK (positive control) or TCT, whereas HOE-140 cancelled both stimuli (Figure 7C). Notably, TCT induced IL-12-producing DCs irrespective of the presence/absence of lisinopril, a rather selective inhibitor angiotensin-converting enzyme (ACEi) (Figure 7). Specificity controls confirmed that HOE-140 did not interfere at all with the magnitude of IL-12 responses induced by lipopolysaccharide (LPS) (Figure 7C). In agreement with the FACS data, ELISA determinations of IL-12 levels in cultures supplemented with HOE-140 confirmed that TCT activate immature DCs through B2R (Figure 7D). Controls in the absence of pathogen indicated that lisinopril or HOE-140 as such did not induce IL-12 production by DCs (Figure 7C). Additionally, DCs cultivated with either TCT or BK (positive control) displayed increased surface expression of CD40 and CD86 (Figure 7E). Of note, HOE-140 cancelled the phenotypic changes induced by TCT (Figure 7E, upper and lower panels), while responses induced by BK were significantly reduced by this B2R antagonist (Figure 7E, lower panel).
Since TCT generate kinins via CZP while invading endothelial cells, we next asked if parasite cysteine proteases were required for DC activation. This question was addressed by pre-incubating TCT with methylpiperazine-Phe-homoPhe-vinylsulfone-benzene (VSPh), an irreversible inhibitor of CZP. After washing the VSPh-TCT, they were added to DC cultures. Whether using FACS and ELISA, we found that VSPh-TCT failed to drive significant IL-12 production by DCs (Figure 7C and 7D), adding weight to the concept that the parasite relies on CZP to generate the innate kinin stimuli.
In order to verify whether the B2R−/− CD11c+ DCs were fully capable of responding to TLR agonists, we compared the in vitro response profile induced by cytosine-phosphate-guanine (CpG) and LPS. As shown in Figure 7F, IL-12 responses were of the same magnitude as compared to wild-type C57BL/6 DCs. Moreover, HOE-140 did not interfere with wild-type DC responsiveness to CpG and LPS (Figure 7F). Notably, the magnitude of B2R−/− DC response to TCT was nearly 10% of IL-12 responses observed in wild-type CD11c+ DCs (Figure 7F). As expected, TCT or BK elicited vigorous IL-12 production in CD11c+ DCs from wild-type mice. In both cases, the IL-12 response was partially blocked by HOE-140 (Figure 7F). In contrast, BK did not induce IL-12 in B2R−/− DCs (Figure 7F).
Adoptive Transfer of CD11c+ DCs from B2R+/+ into Susceptible B2R−/− Mice Restored Host Capability to Control Infection through Induction of Type-1 Effector T Cells
As mentioned earlier, we found that production of IFN-γ by Ag-experienced CD4+ and CD8+ T cells from B2R−/− spleen and heart declined sharply as the infection continued (28 d p.i.). In view of those findings, we asked whether the deficient type-1 responses of B2R−/− mice were restored upon adoptive transfer of wild-type DCs. To address this question, we adoptively transferred (intravenously) immature B2R+/+ CD11c+ DCs (106 cells) into B2R−/− mice before injection of the parasites. As controls, recipient B2R−/− mice received an equivalent number of CD11c+ DCs isolated from donor B2R−/− spleen. As expected, our controls showed that B2R−/− mice succumbed (100% mortality, n = 5; three independent experiments) at day 30. In contrast, 100% of the B2R−/− recipient mice reconstituted with B2R+/+ DCs survived the acute challenge. Of note, the mice of the specificity control group (B2R−/− DCs → B2R−/− mice) succumbed (100%) to the infection, thus ruling out the possibility that adaptive immune function was restored due to non-specific activation of these APCs during the DC isolation procedure. We then ran another set of experiments to verify if the DC transfer maneuver had restored (type-1) acquired immunity of B2R−/− recipient mice. Recall assays performed at day 28 p.i. confirmed that splenic or intracardiac (CD4+ or CD8+) T cells from control B2R−/− mice secreted lower levels of IFN-γ as compared to experienced CD4+ or CD8+ T cells isolated from B2R+/+ spleen or heart (Figure 8A). Notably, B2R−/− mice that received adoptive transfer of B2R+/+ DCs recovered the ability to generate IFN-γ-producing CD4+ and CD8+ T cells (Figure 8A). Conversely, the DC transfer to B2R−/− mice repressed the secretion of IL-17 (Figure 8B) and TNF-α (Figure 8C) by Ag-experienced (splenic or intracardiac) CD4+ T cells of the reconstituted B2R−/− mice, therefore simulating the phenotype of wild-type-infected mice.
Assessment of cytokine production by splenic and heart-derived CD4+ and CD8+ T cells isolated (28 d p.i.) from B2R+/+, B2R−/−, and B2R−/− recipient mice. The transfer of CD11c+ DCs (spleen B2R+/+) into B2R−/− mice was carried out by the intravenous route. Purified T cells were co-cultured with CD11c+ DCs loaded with T. cruzi Ag (25 μg/ml) for 72 h at 37 °C. Culture supernatants were harvested and assayed for IFN-γ (A), IL-17 (B), and TNF-α (C) levels by ELISA. Values are the mean ± SD from one representative experiment with individual cells from five mice/group. Statistics were done by ANOVA and pair-wise comparisons were done by the Tukey test (*, p < 0.05).
In the present work, we have demonstrated that the immune dysfunction of B2R−/− mice infected intraperitoneally with T. cruzi is a consequence of defective sensing of endogenously released kinins by immature CD11c+ DCs. Our analysis of the adaptive immune responses of infected B2R−/− appointed a role for the kinin signaling pathway in the development of type-1 effector T cells. The critical importance of DCs as sensors of kinins was confirmed by adoptive cell transfers (wild type DC→ B2R−/− mice), which reversed the susceptible phenotype of B2R−/− mice while restoring the development of type-1 effector T cells, both in the spleen and cardiac tissues of recipient B2R−/− mice.
The notion that the kinin-releasing trypomastigotes induce DC maturation through B2R is supported by the following experimental evidence. First, our in vitro studies showed that TCT vigorously induced IL-12 responses in splenic DCs originating from wild-type (C57BL/6) mice, while failing to activate B2R−/− DCs. Second, we demonstrated that HOE-140, a specific antagonist of B2R, efficiently blocked DC maturation (IL-12 induction, upregulation of CD80, CD86, and CD40). Furthermore, the irreversible inhibitor of CZP (K11777) mitigated the IL-12 stimulatory activity (B2R-driven) of TCT, thus implicating the major cysteine protease of T. cruzi in the kinin generation mechanism. Extending these observations to the in vivo settings, we then analyzed IL-12 production by splenic CD11c+ DCs isolated 18 h after systemic inoculation (intravenously) of Dm28c TCT. Experiments performed with BALB/c mice showed that mice pre-treated with HOE-140 presented reduced frequencies of splenic CD11c+ IL-12+ DCs. Adding weight to these results, we demonstrated that TCT induced high frequencies of CD11c+ IL-12+ DCs in wild-type (C57BL/6) spleen, while failing to evoke significant IL-12 responses in DCs isolated from B2R−/− spleen. Notably, preliminary studies indicated that macrophages (CD11b+F4/80+) isolated from the spleen of these wild-type and B2R−/− mice develop comparable IL-12 responses. Given that type-1 immune responses in the spleen of B2R−/− mice are well preserved at day 14 p.i., it is possible that macrophages activated by alternative routes provide the IL-12 signals that drive adaptive immunity in this secondary lymphoid tissue.
Although we cannot claim that conventional DCs are the primary or even unique in vivo targets of T. cruzi in the spleen, the above mentioned results support the concept that kinin-releasing pathogens may drive DC maturation in vivo through the activation of G-protein-coupled B2 receptors . Since lymphoid tissues are irrigated by non-fenestrated capillaries, we may predict that trypomastigotes invading the splenic stroma are faced with an abundant supply of blood-borne proteins, such as kininogens. Given biochemical evidence that interactions of high molecular weight kininogens with heparan sulfate proteoglycans potentiate the kinin-releasing activity of CZP , it is plausible that the extracellular trypomastigotes might promptly liberate these paracrine signaling peptides while moving through extracellular matrices, hence driving DC maturation via B2R [31,32].
At first sight, our finding that TCT induce DC maturation via the endogenous kinin/B2R pathway appears to conflict with the well-established concept that innate sentinel cells sense pathogens via pattern recognition receptors (PRRs), such as the members of the TLR family [28,44]. Indeed, early studies of macrophage (IFN-γ-primed) interaction with T. cruzi (Y strain) suggested that TLR2 and TLR4 ligands [20–22] are major drivers of innate responses in T. cruzi infection. In a limited attempt to investigate the functional relationship of B2R and TLRs, we examined the outcome of TCT interaction in vitro with CD11c+ DCs (splenic origin) derived from either TLR2−/− or TLR4d/d mice. Our results indicated that TCT induced vigorous IL-12 responses both in TLR2−/− DCs and TLR4d/d DCs (unpublished data). Moreover, we found that addition of HOE-140 to the TCT/DC culture system blocked IL-12 responses by TLR2−/− or TLR4d/d DCs (unpublished data). Admittedly, complementary studies with DCs from double TLR2/TLR4 knockout mice and MyD88−/− mice are required to rule out the possibility that B2R-responsive phenotypes of TLR2−/− DCs and TLR4d/d DCs reflect compensatory responses, respectively induced by TLR4 and TLR2 ligands of T. cruzi [20–22]. The intertwined nature of the innate pathways controlling IL-12 production by APCs is illustrated by the recent demonstration  that T. cruzi DNA potently induces IL-12 production by mouse macrophages through the activation of TLR9. Given the evidence that DCs are parasitized by T. cruzi , it will be interesting to determine if endogenous (BK/LBK) and exogenous (T. cruzi DNA) danger signals may activate their respective sensor receptors, B2R and TLR9, at distinct temporal stages (i.e., early and late) of intracellular infection.
While examining the frequencies of type-1 effectors in extra-lymphoid and lymphoid tissues of wild-type and B2R−/−-infected mice, we became aware that B2R deficiency affected the temporal and spatial distribution of IFN-γ-producing CD4+ and CD8+ T cells. Recall assays performed at day 14 p.i. revealed weakened IFN-γ production by intracardiac CD4+ and CD8+ T cells isolated from B2R−/− mice. However, we found high and comparable frequencies of INF-γ-producing T cells in the spleen of the same B2R−/− and wild-type mice. Since the parasites are scarcely found in the spleens of wild-type and B2R−/− mice, we may infer that activation of the kinin/B2R pathway is dispensable for early induction of type-1 effectors in the spleen. Adoptive cell transfer studies are required to find out if the induction of these early type-1 effector T cells is controlled by MyD88-coupled pathways , such as those triggered by TLR2/TLR9  and/or by IL-1R/IL-18 R . In addition, it is possible that IL-12 induction by the NKT/CD1 pathway  may also contribute to early development of type-1 effectors in lymphoid tissues.
It is intriguing that intracardiac CD4+ and CD8+ T cells from B2R−/− mice (14 d p.i.) showed impaired production of IFN-γ, despite the fact that the spleen of these mice displayed high frequencies of type-1 effectors. Coincidently, tissue parasite burden is drastically increased in B2R−/− heart, thus showing an inverse correlation between these two parameters at day 14 p.i. Although we cannot a priori assume that Ag specificities of T cells recruited to the heart of wild-type and B2R−/− mice at 14 d p.i. are necessarily the same, independent studies performed with the Brazil  and Y strain of T. cruzi  converged in appointing cytotoxic CD8+ T cells as the key effectors controlling intracellular parasite outgrowth in cardiac tissues. So far, efforts to characterize the Ag specificity of intracardiac CD8+ T cells in our infection model have been hampered by the findings that Dm28c T. cruzi strain did not present open reading frames for genes coding for ASP-2 antigens , which in other systems provide dominant epitopes recognized by cytotoxic CD8+ T cells [46,47]. In spite of these limitations, it is conceivable that immunoregulatory dysfunctions were responsible for the weakened type-1 responses observed in peripheral T cells from B2R−/− mice. For example, it is possible that the migratory competence of effector T cells generated in lymphoid tissues may depend on DC activation via the kinin/B2R pathway. Pertinently, recent analysis of the susceptible phenotype of CCR5−/− mice infected with T. cruzi implicated this chemokine receptor in the recruitment of CD8+ and CD4+ effector T cells into infected heart [13,14]. Given these precedent findings, it will be worthwhile investigating if B2R and CCR5 signaling, whether acting separately or in conjunction, might promote the migration of effector T cells to peripheral sites of infection, such as the heart.
As the infection advanced (14→28 d), wild-type mice developed high frequencies of IFN-γ-producing CD4+ and CD8+ effector T cells, both in the spleen and heart. Interestingly, a significant proportion of these Ag-responsive T cells displayed activated (CD44+) phenotypes. In contrast, B2R−/− mice showed negligible frequencies of activated type-1 effectors at day 28, both in spleen and heart. Of note, we found that the intracardiac CD4+ and CD8+ T populations recovered from the CD3+ pool of B2R−/− mice were significantly contracted (Figure 5). Considering that B2R−/− mice recovered the capacity to mount protective type-1 responses upon adoptive transfer of wild-type DCs, it is possible that maintenance of T cell homeostasis may depend, at least to some degree, on DC responses elicited by endogenously released kinins. Albeit speculative, this hypothesis is worth exploring in light of independent reports showing that aberrant T cell apoptosis is the primary cause of the immunoregulatory abnormalities underlying host susceptibility to acute infection by the Dm28c strain of T. cruzi .
Another intriguing phenotypic characteristic of infected B2R−/− mice emerged when we monitored production of IL-17 and TNF-α in our recall assays. Unexpectedly, we found that the weakened TH1 responses of B2R−/− CD4+ T cells (whether isolated from the spleen/heart) at day 28 d p.i. was accompanied by upregulated production of IL-17 and TNF-α, two pro-inflammatory cytokines associated with the effector activity of TH17 cells. Recently characterized as a separate lineage of pro-inflammatory T helper cells distinct from conventional TH1 and TH2 cells [42,43], TH17 cells differentiate from naïve precursors under the critical influence of IL-6 and TGF-β1 . It is also known that committed TH17 cells depend on the IL-23 survival signal to develop their pro-inflammatory function in vivo . Notably, at early stages of infection (14 d p.i.), there was no significant production of IL-17 and TNF-α by spleen- or heart-derived T cells from infected B2R−/− mice, whether detected by conventional recall assays or polyclonal activation with anti-CD3 antibodies (unpublished data). It is unclear why the TH1/TH17 balance was inverted as the acute infection progressed in B2R−/− mice. Recently, IL-27 was identified as the cytokine that suppresses TH17 differentiation driven by IL-6 and TGF-β via STAT-1, independently of IFN-γ . Interestingly, T. cruzi–infected WSX-1 mice (deficient in the IL-27Ra)  develop severe hepatic injury, correlating with overproduction of various pro-inflammatory cytokines, such as IL-6, TNF-α, and IFN-γ . Although TH17 responses were not evaluated in T. cruzi–infected WSX-1 mice, these animals strongly upregulated TH2 cytokines . However, we were unable to detect IL-4 production or IgG isotype switching in infected B2R−/− mice, indicating that these mice strains do not share the same phenotype. Importantly, the recovery of type-1 responses in DC recipient B2R−/− mice was associated with reduced production of IL-17 and TNF-α. Additional studies are underway to determine if DCs activated by the kinin/B2R pathway may influence TH1/TH17 lineage development in T. cruzi infection via IL-27, or through alternative mechanisms.
Collectively, our results have linked development of acquired resistance to T. cruzi infection to DC functional responses controlled by the kinin/B2R signaling pathway. Our study provides a paradigm for investigations of the innate role of endogenously released kinin “danger” signals in TH1/TH17 development in other infections and inflammatory diseases.
Materials and Methods
Mice and parasites.
Experiments were done with mouse strains BALB/c, C57BL/6 WT (B2R+/+), and C57BL/6 B2R−/− . TCT (Dm28c clone of T. cruzi) were harvested from the supernatants of infected LLC-MK2 cultures maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 2% FCS. Freshly released parasites were washed 3X with excess PBS before being used in experiments. Epimastigotes (EPI) of Dm28c clone of T. cruzi were cultivated in standard liver infusion tryptose medium (LIT) containing 10% FCS (GIBCO). Where indicated, TCT were pre-incubated for 20 min at RT with 10 μM of VSPh.
In vitro activation of CD11c+ DC isolated from normal mouse spleen.
Splenic DCs were isolated with anti-CD11c magnetic beads (Miltenyi Biotec) and stimulated in vitro with TCT (3 × 106/well) in DMEM/10% fresh FCS for 18 h at 37 °C in the presence or absence of 25 μM lisinopril (Lis; Sigma), an inhibitor of the angiotensin converting enzyme (ACEi) and/or 0.1 μM HOE-140, as indicated. In some experiments, DCs were treated with VSPh-TCT. Controls were done with 10 nM BK, 10 ng/ml LPS, or 100 ng/ml CpG. For intracellular staining of IL-12, 1 × 106 DCs were washed and pre-incubated with 2% of normal mouse serum (NMS) supplemented with anti-mouse CD16/CD32 FCγ III/II receptor (clone 2.4G2) (1 μg/106 cells) (BD Biosciences). The washed cells were stained with anti-mouse CD11c-FITC (BD Biosciences) in PBS/2% NMS. After washing (2X PBS), the cells were fixed in 2% paraformaldehyde, washed, and permeabilized with 0.05% saponin (Sigma-Aldrich). Staining with PE-labeled anti-IL-12 p40/p70 (BD Biosciences) was performed in PBS/2% NMS/0.5% saponin. Surface expression of co-stimulatory proteins was monitored by incubating DCs with antibodies to CD40 or CD86 (BD Biosciences) in the presence of PBS/2% NMS. Isotype-matched control was performed with rat IgG-FITC or IgG1-PE (BD Biosciences). Samples were analyzed by (FACSCalibur) (BD Biosciences), and data analyses were done with CELLQuest software (BD Biosciences) or Win-MDI software (TSRI).
Isolation and characterization of DCs from mice infected with T. cruzi.
Mice were pre-treated or not with 10 mg/kg intraperitoneally of ACEi (captopril) and/or 100 μg/kg subcutaneously of HOE-140, as indicated, and 1 h later the mice were injected intravenously with 1 × 106 TCT. DCs were isolated from spleen at 18 h p.i. Briefly, pooled lymph node fragments were treated with collagenase D (Sigma-Aldrich), and CD11c+ DCs were positively selected using magnetic beads covered with anti-mouse CD11c (Miltenyi Biotec; 90% pure). CD11c+ DCs (106 cells/well) were incubated for 4 h in RPMI complete medium with 10 μg/ml brefeldin A (Sigma-Aldrich) and were stained for CD11c and IL-12 p40/p70 as described above.
Cytokine production by spleen- and heart-derived T cells isolated from T. cruzi–infected mice.
B2R+/+ and B2R−/− mice were infected by the intraperitoneal route with 6 × 105 TCT. After 28 d, splenocytes were recovered and were stimulated with 25 μg/ml boiled soluble T. cruzi antigen (EPI-Ag). Total CD3+ T cells (T cell Enrichment column; R&D Systems) were purified from either spleen or heart of infected B2R+/+ or B2R−/− mice (14 d and 28 d p.i.). CD4+ and CD8+ T cells were also purified (14 d and 28 d p.i.) from spleen or heart of infected mice with magnetic microbeads conjugated to anti-mouse CD4+ and CD8+ (Miltenyi Biotec) and isolated by passing over a MACs LS+ column held in a VarioMACS magnetic separator (Miltenyi Biotec). Positively selected cells were 85%–95% pure, as determined by flow cytometry analysis. Recall assays were performed by co-culturing 1 × 106 CD3+, CD4+, or CD8+ T cells with 1 × 104 splenic CD11c+ DCs from B2R+/+ mice as APCs loaded with 25 μg/ml boiled soluble T. cruzi antigen (EPI-Ag). Culture supernatants were collected after 72 h and cytokines (IFN-γ, IL-17, TNF-α) were quantified by ELISA utilizing purified and biotinylated Abs (R&D Systems). Values are presented as pg cytokine/ml (mean ± SD). Statistical differences between mean values were evaluated by ANOVA, and pair-wise comparisons were done by the Tukey test.
B2R+/+- and B2R−/−-infected mice were killed at the time points indicated (14 d and 28 d p.i.) and single cell suspensions were prepared from the spleen and heart. Red blood cell–depleted cells were stimulated with 25 μg/ml boiled soluble T. cruzi antigen (EPI-Ag) and treated with anti-mouse CD16/CD32 FCγ III/II receptor before staining. Cells were then fixed in 2% paraformaldehyde and stained with FITC-labeled mouse antibody against CD4 or CD8, and PE-Cy-labeled mouse antibody against CD44 (BD Biosciences). For intracellular staining, stimulated cells were treated with brefeldin A (BD Biosciences) and stained with PE-labeled anti-IFN (XMG1.2; eBiosciences). Samples were analyzed by FACSCalibur (BD Biosciences), and data analyses were done with CELLQuest software (BD Biosciences).
Quantification of tissue parasite loads by qPCR.
qPCR for parasite quantification was performed as described previously  with minor modifications. Briefly, DNA was isolated from spleen and heart tissues of B2R+/+ and B2R−/− mice infected by the intraperitoneal route with 6 × 105 TCT, after digestion with proteinase K, followed by a phenol-chloroform-isoamyl alcohol affinity extraction. q-PCR using 100 ng of total DNA was performed on an ABI PRISM 7900 sequence detection system (Applied Biosystems) using SYBR Green PCR Master Mix according to the manufacturer's recommendations. Purified T. cruzi DNA (American Type Culture Collection) was sequentially diluted for curve generation in aqueous solution containing equivalent amounts of DNA from uninfected mouse tissues. The equivalence of host DNA between samples was normalized by levels of genomic beta-2 microglobulin (B2m) gene in the same samples. The following primers were used for T. cruzi genomic DNA, TCZ, GCTCTTGCCCACACGGGTGC (forward), and CCAAGCAGCGGATAGTTCAGG (reverse); and for genomic B2m, CTGAGCTCTGTTTTCGTCTG (forward) and TATCAGTCTCAGTGGGGGTG (reverse).
Quantitative determination of IFNγ levels by qPCR.
B2R+/+ and B2R−/− mice were infected with 1 × 104 trypomastigotes of the Brazil strain. Hearts were obtained at 15 d and 30 d p.i. RNA from the tissues was isolated using the Trizol LS reagent following the manufacturer's protocol. Briefly, 5 ng of RNA was reverse-transcribed in a final volume of 20 μl using Superscipt II transcriptase (Invitrogen). The reverse transcription mixture consisted of 1 mM dNTPs (Pharmacia Biotech), 20 mM dithiothreitol, 50 mM Tris HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 2 ng hexamer (Pharmacia Biotech), and 200 U of superscript RT RNase H- reverse transcriptase (Invitrogen). The reaction was incubated for 50 min at 42 °C. The qPCR primers for IFN-γ were 5′ forward GCGGCCTAGCTCTGAGACAA and 5′ reverse GACTGTGCCGTGGCAGTAAC, which amplified the 97-bp IFN-γ gene fragment. qPCR was carried out using magnesium chloride (2 mM), primers, and the PCR Sybr Green Master Mix (Roche Applied Science) in a final volume of 20 μl. The reaction conditions for qPCR used for quantification of IFN-γ have been previously described . A standard curve for the quantification of IFN-γ was developed in the range of 0.5 pg pg using the primers at same conditions. The result was normalized using GAPDH mRNA for each sample. The primer sequence and the conditions used for the real-time PCR quantification were the same as previously published .
Figure S1. B2R−/− Mice Are Also Susceptible to Brazil T. cruzi Strain Infection by the Intraperitoneal Route
Temporal course of infection with the Brazil T. cruzi strain in B2R+/+ and B2R−/− mice. Parasitemia and survival curves of mice groups intraperitoneally infected with 1 × 104 TCT of the Brazil strain of T. cruzi. Parasitemia were evaluated with 5 μl of each infected mouse's blood in an optical microscope. Mortality was recorded daily. The data are representative of two independent experiments (n = 10 mice/group).
(949 KB TIF)
Figure S2. Immature DCs Sense TCT via the Kinin/B2R Activation Pathway
(A) IL-12 production by splenic CD11c+ DCs of infected mice. BALB/c male mice were pre-treated or not with HOE-140 (100 μg/kg) for 1 h prior to injection of 1 × 106 TCT intravenously. Non-infected ACEi-treated animals served as control. CD11c+ DCs were isolated from spleen of infected BALB/c at 18 h p.i. and cultured in RPMI complete medium. FACS profiles were done with CD11c-FITC and anti-IL12-PE. Each bar represents the % of DCs producing IL-12 beyond threshold levels. Data represent the mean ± SD from two independent experiments (n = 6 mice/group). Statistics were done by ANOVA and pair-wise comparisons (represented by a, b, c, d) were done by the Tukey test (*, p < 0.05).
(870 KB TIF)
The authors wish to thank Dr. J. H. McKerrow (UCSF) for donation of the synthetic inhibitor of cruzipain (K11777). We also thank Dr. Ricardo T. Gazzinelli (CPRR, Fiocruz) and Dr. Helton Santiago (CPRR, Fiocruz) for intensive discussions and for kindly performing analysis of parasite load in heart and splenic tissues by quantitative real-time PCR. We wish to acknowledge Leila Faustino, Daniela O. Faustino, Alda F. Alves, and Vitaliy Shtutin for technical assistance. We also thank Dr. Marcelo Bozza (UFRJ) for reviewing the manuscript.
ACM and JS conceived and designed the experiments. ACM, VS, LBdA, FN, AG, and HBT performed the experiments. ACM, VS, AM, LBdA, WME, HBT, and JS analyzed the data. JBP, WME, HBT, and JS contributed reagents/materials/analysis tools. ACM, AM, and JS wrote the paper.
- 1. Freitas HF, Chizzola PR, Paes AT, Lima AC, Mansur AJ (2005) Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease. Int J Cardiol 102: 239–247.
- 2. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV (2007) Pathogenesis of chronic Chagas heart disease. Circulation 115: 1109–1123.
- 3. Tarleton RL (2003) Chagas disease: a role for autoimmunity? Trends Parasitol 19: 447–451.
- 4. Higuchi MD, Ries MM, Aiello VD, Benvenuti LA, Gutierrez PS, et al. (1997) Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 56: 485–489.
- 5. Bellotti G, Bocchi EA, de Moraes AV, Higuchi ML, Barbero-Marcial M, et al. (1996) In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Am Heart J 131: 301–307.
- 6. Zhang L, Tarleton RL (1999) Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J Infect Dis 180: 480–486.
- 7. Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, et al. (2005) Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun 73: 7960–7966.
- 8. Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, et al. (2004) Frequency of interferon-gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 189: 909–918.
- 9. Tarleton RL, Grusby MJ, Postan M, Glimcher LH (1996) Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int Immunol 8: 13–22.
- 10. Kumar S, Tarleton RL (1998) The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol 20: 207–216.
- 11. Martin DL, Tarleton RL (2005) Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection. J Immunol 174: 1594–1601.
- 12. Tzelepis F, de Alencar BC, Penido ML, Gazzinelli RT, Persechini PM, Rodrigues MM (2006) Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice. Infect Immun 74: 2477–2481.
- 13. Machado FS, Koyama NS, Carregaro V, Ferreira BR, Milanezi CM, et al. (2005) CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J Infect Dis 191: 627–636.
- 14. Hardison JL, Wrightsman RA, Carpenter PM, Kuziel WA, Lane TE, et al. (2006) The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun 74: 135–143.
- 15. Martin DL, Weatherly DB, Laucella SA, Cabinian MA, Crim MT, et al. (2006) CD8+ T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PloS Pathog. 2. https://doi.org/10.1371/journal.ppat.0020077
- 16. Leavey JK, Tarleton RL (2003) Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. J Immunol 170: 2264–2268.
- 17. Grisotto MG, D'Imperio Lima MR, Marinho CR, Tadokoro CE, Abrahamsohn IA, et al. (2001) Most parasite-specific CD8+ T cells in Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell receptor-alphabeta and CD8 molecules. Immunology 102: 209–217.
- 18. Albareda MC, Laucella SA, Alvarez MG, Armenti AH, Bertochi G, et al. (2006) Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int Immunol 18: 465–471.
- 19. Silva JS, Vespa GN, Cardoso MA, Aliberti JC, Cunha FQ (1995) Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 63: 4862–4867.
- 20. Campos MA, Almeida IC, Takeuchi O, Akira S, Valente EP, et al. (2001) Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 167: 416–423.
- 21. Ouaissi A, Guilvard E, Delneste Y, Caron G, Magistrelli G, et al. (2002) The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection. J Immunol 168: 6366–6374.
- 22. Oliveira AC, Peixoto JR, Arruda LB, Campos MA, Gazzinelli RT, et al. (2004) Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J Immunol 173: 5688–5696.
- 23. Bafica A, Santiago HC, Goldszmid R, Ropert C, Gazzinelli RT, et al. (2006) Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol 177: 3515–3519.
- 24. Campos MA, Closel M, Valente EP, Cardoso JE, Akira S, et al. (2004) Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. J Immunol 172: 1711–1718.
- 25. Koga R, Hamano S, Kuwata H, Atarashi K, Ogawa M, et al. (2006) TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi. J Immunol 177: 7059–7066.
- 26. Costa VM, Torres KC, Mendonca RZ, Gresser I, Gollob KJ, et al. (2006) Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection. J Immunol 177: 3193–3200.
- 27. Galvao Da Silva AP, Jacysyn JF, De Almeida Abrahamsohn I (2003) Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response. Immunology 108: 230–237.
- 28. Ropert C, Gazzinelli RT (2007) Innate recognition, cell signaling and pro-inflammatory responses during infection with Trypanosoma cruzi. In: Denkers EY, Gazzinelli RT, editors. Protozoans in macrophages. Austin (Texas): Landes Biosciences. pp. 49–66.
- 29. Duthie MS, Kahn M, White M, Kapur RP, Kahn SJ (2005) Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection. Infect Immun 73: 1890–1894.
- 30. Aliberti J, Viola JP, Vieira-de-Abreu A, Bozza PT, Sher AJ, et al. (2003) Cutting edge: bradykinin induces IL-12 production by dendritic cells: a danger signal that drives TH1 polarization. J Immunol 170: 5349–5353.
- 31. Monteiro AC, Schmitz V, Gazzinelli RT, Almeida IC, Todorov A, et al. (2006) Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi. J Immunol 177: 6325–6335.
- 32. Scharfstein J, Schmitz V, Svensjo E, Granato A, Monteiro AC (2007) Kininogens coordinate adaptive immunity through the proteolytic release of bradykinin, an endogenous danger signal driving dendritic cell maturation. Scand J Immunol 66: 128–136.
- 33. Bhoola KD, Figueroa CD, Worthy K (1992) Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44: 1–80.
- 34. Farmer SG, Burch RM (1992) Biochemical and molecular pharmacology of kinin receptors. Annu Rev Pharmacol Toxicol 32: 511–536.
- 35. Marceau F, Bachvarov DR (1998) Kinin receptors. Clin Rev Allergy Immunol 16: 385–401.
- 36. Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL (2005) Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57: 27–77.
- 37. Imamura T, Pike RN, Potempa J, Travis J (1994) Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J Clin Invest 94: 361–367.
- 38. Del Nery E, Juliano MA, Lima AP, Scharfstein J, Juliano L (1997) Kininogenase activity by the major cysteinyl proteinase (cruzipain) from Trypanosoma cruzi. J Biol Chem 272: 25713–25718.
- 39. Scharfstein J, Schmitz V, Morandi V, Capella MM, Lima AP, et al. (2000) Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J Exp Med 192: 1289–1300.
- 40. Lima AP, Almeida PC, Tersariol IL, Schmitz V, Schmaier AH, et al. (2002) Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain. J Biol Chem 277: 5875–5881.
- 41. Scharfstein J (2003) Activation of bradykinin-receptors by Trypanosoma cruzi: a role for cruzipain in microvascular pathology. In: Kelly JM, editor. Molecular mechanisms of pathogenesis in Chagas disease. Austin (Texas): Landes Bioscience. pp. SA 111–137.
- 42. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123–1132.
- 43. Park H, Li Z, Yang XO, Chang SH, Nurieva R, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133–1141.
- 44. Trinchieri G, Sher A (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7: 179–190.
- 45. Van Overtvelt L, Vanderheyde N, Verhasselt V, Ismaili J, De Vos L, et al. (1999) Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infection Immun 67: 4033–4040.
- 46. Padilla A, Xu D, Martin D, Tarleton R (2007) Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells. Infect Immun 75: 231–235.
- 47. Tzelepis F, de Alencar BC, Penido ML, Gazzinelli RT, Persechini PM, Rodrigues MM (2006) Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice. Infect Immun 74: 2477–2481.
- 48. Claser C, Espíndola NM, Sasso G, Vaz AJ, Boscardin SB, Rodrigues MM (2007) Immunologically relevant strain polymorphism in the Amastigote Surface Protein 2 of Trypanosoma cruzi. Microbes Infect 9: 1011–1019.
- 49. Freire-de-Lima CG, Nascimento DO, Soares MB, Bozza PT, Castro-Faria-Neto HC, et al. (2000) Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403: 199–203.
- 50. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, et al. (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231–234.
- 51. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, et al. (2006) Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7: 929–936.
- 52. Hamano S, Himeno K, Miyazaki Y, Ishii K, Yamanaka A, et al. (2003) WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19: 657–667.
- 53. Pesquero JB, Araujo RC, Heppenstall PA, Stucky CL, Silva Jr JA, et al. (2000) Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci USA 97: 8140–8145.
- 54. Cummings KL, Tarleton RL (2003) Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol Biochem Parasitol 129: 53–59.
- 55. Bouzahzah B, Nagajyothi F, Desruisseaux MS, Krishnamachary M, Factor SM, et al. (2006) Cell cycle regulatory proteins in the liver in murine Trypanosoma cruzi infection. Cell Cycle 5: 2396–2400.